AI-generated analysis. Always verify with the original filing.
Senti Biosciences, Inc. entered into a First Amendment to Lease effective September 1, 2025, reducing leased premises from approximately 91,910 to 45,955 rentable square feet and monthly base rent starting at $188,311, with the landlord entitled to draw $2.0 million from the company's letter of credit. Related amendments to sublease with GeneFab, LLC and landlord consent involve matching rent terms, a $1.0 million reduction fee, and settlement of GeneFab's $1,374,005 outstanding rent via prepayment credit.
Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement. Lease Amendment On March 17, 2026, Senti Biosciences, Inc. (the “Company”) entered into a First Amendment to Lease (
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATUR
Material Agreement